Ashley Fraser and Clara Zacharko, CRA Life Sciences Practice, Toronto look at what revised guidelines to the Patented Medicine Prices Review Board means for drug pricing in Canada.
We speak to professor Janet Hemingway, the founding director of the Infection Innovation Consortium (iiCON) to find out all about the work the organisation has done throughout the Covid-19 pandemic.
Dr Toby Astill, global market manager - Cannabis and Hemp Markets at PerkinElmer, talks about the growth of cannabis in the pharmaceutical industry and the importance of chromatography to this sector.
Gary Connors, partner at Oliver Wight looks at why the pharmaceutical sector is lagging behind other sectors in removing plastic from their products and processes?
